type here...

CATEGORIES

Medication

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

Medika Life -
How can patients with psychiatric or any other illnesses be viewed as non-compliant with their medical regimes when there is a persistent failure to investigate how their race and genetics are affecting treatment

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Christopher Nial -
While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne -
Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the study through a nonprofit foundation and seek not legalization

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories